Table 2.

Raw Data for CMR‐FT Strain Parameters

CMR‐FT strain (%)	Placebo (n=26)	IV (n=27)	P value
7‐d visit
LV 3D‐GLS	−5.9±3.2	−7.1±2.6	0.178
LV 3D‐GCS	−8.5±3.4	−9.6±3.3	0.256
LV 3D‐GRS	11.4±4.6	14.0±5.7	0.073
RV 2D‐GLS	−15.0±6.0	−14.5±5.1	0.755
RV 2D‐GCS	−9.1±4.6	−10.2±4.4	0.353
RV 2D‐GRS	14.9±6.9	15.9±9.7	0.642
30‐d visit
LV 3D‐GLS	−6.4±3.1	−8.5±3.7	0.030
LV 3D‐GCS	−9.4±3.8	−10.8±3.0	0.143
LV 3D‐GRS	12.5±4.6	16.9±6.5	0.008
RV 2D‐GLS	−15.2±5.4	−16.1±5.6	0.574
RV 2D‐GCS	−7.9±6.1	−12.0±4.2	0.006
RV 2D‐GRS	14.2±6.4	18.2±8.7	0.040

Values are expressed as mean±SD. CMR‐FT indicates cardiac magnetic resonance feature tracking; LV 3D‐GCS, left ventricle 3D‐global circumferential strain; LV 3D‐GLS, left ventricle 3D‐global longitudinal strain; LV 3D‐GRS, left ventricle 3D‐global radial strain; RV 2D‐GCS, right ventricle 2D‐global circumferential strain; RV 2D‐GLS, right ventricle 2D‐global longitudinal strain; and RV 2D‐GRS, right ventricle 2D‐global radial strain.